Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbodiimide Mediated Amidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110283109B reveals a novel amidation-first route for Racecadotril, offering superior purity and scalable crystallization for reliable pharmaceutical intermediate supply.